Dry mouth (xerostomia) may occur in some patients taking tirzepatide, potentially related to dehydration from gastrointestinal side effects or changes in fluid balance
Export detailed reports to analyze trends over time
Semaglutide was associated with gastrointestinal adverse events (nausea, vomiting, diarrhea, constipation) which were of mild to moderate severity, short duration, and resolved without treatment discontinuation ( Notably, a recent systematic review showed that compared to other semaglutide doses and GLP-1 RAs, 2.4 mg semaglutide had the greatest effect on weight reduction, controlling glucose level, and reducing BP
For further guidance on aseptic preparation and beyond-use dating of injectable products in UK practice, refer to SPS (Specialist Pharmacy Service) resources and MHRA guidance on the manufacture of IMPs
Eat before drinking: Having food in your stomach helps stabilize blood sugar
Common weight loss peptides and their specific calculations Each weight loss peptide has established dosing ranges based on research literature
